0.00Open0.00Pre Close0 Volume0 Open Interest87.00Strike Price0.00Turnover135.48%IV-11.40%PremiumNov 29, 2024Expiry Date8.90Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9680Delta0.0162Gamma8.73Leverage Ratio-0.2210Theta-0.0012Rho-8.45Eff Leverage0.0024Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet